The Silicon Review ^Asia

CureApp, Inc. received regulatory authorization for sale and manufacturing of the CureApp SC Nicotine Addiction Treatment App and CO Checker. The new solution is Asia’s first therapeutics app, and it got approval from the Ministry of Health, Labor, and Welfare. The company is looking forward to releasing the app by the end of FY2020, and it is working relentlessly with new plans to receive insurance reimbursement. The CureApp SC was made to aid patients receiving outpatient treatment, which is a new attempt to help them quit smoke from their homes.

There are three notable components in the app: a doctor app, a patient app, and a portable CO checker. The patient app will take advantage of the fact that people always have their smartphones with them, and this is a better way to deliver personalized guidance based on their therapy condition and status. The CO checker will help the patients in measuring the level of carbon monoxide in their breath. Before the app’s advent, there used to be a gap in treating patients in the office and home setting. By helping the patients in a familiar setup success rate of smoking cessation was improved notably.